Physician Assistant · Oklahoma City, OK
NPI
1144466558
Since 2009
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
940 NE 13th St, 2b1409
Oklahoma City, OK, 73104
Phone (405) 271-8685
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$3.5M
162 prescriptions
Company payments, 2025
$267
From 9 companies
Medicare prescription drug claims, 2024
In 2024, the drug Ashley C Taylor prescribed most often to Medicare patients was Palynziq (Pegvaliase-Pqpz), with 34 prescriptions and refills. In total Ashley C Taylor wrote 162 Medicare prescriptions that cost $3.5M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-10-05.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Palynziq Pegvaliase-Pqpz | 34 | 34 | Under 11 | $1.8M |
| Strensiq Asfotase Alfa | 18 | 18 | Under 11 | $1.6M |
| Cyclobenzaprine Hcl Generic | 12 | 18 | Under 11 | $147 |
Brand drugs: 58 claims; generic drugs: 104 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ashley C Taylor $267 ($267 in general payments such as food, travel and fees) from 9 companies. The largest payer was BioMarin Pharmaceutical Inc. with $65.45.
| Company | Payments | Amount |
|---|---|---|
| BioMarin Pharmaceutical Inc. BMRN | 2 | $65.45 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $36.39 |
| PTC Therapeutics, Inc. PTCT | 2 | $31.6 |
| Janssen Biotech, Inc. JNJ | 1 | $31.59 |
| IntraBio Inc | 1 | $29.83 |
| Cycle Pharmaceuticals Inc | 1 | $19.63 |
| Janssen Pharmaceuticals, Inc JNJ | 1 | $18.86 |
| Medunik USA Inc. | 1 | $18.27 |
| Genzyme Corporation SNY | 1 | $14.97 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.